Gennev Founder Jill Angelo Steps Down After Acquisition; Aurion Biotech CEO Replaced Following Alcon Majority Stake; Temporal Adds New Leadership
Jill Angelo, founder and CEO of menopause startup Gennev, stepped down following its acquisition by Unified Women’s Healthcare, while Aurion Biotech replaced CEO Greg Kunst with Arnaud Lacoste after Alcon acquired a majority stake. Temporal also announced leadership additions with Jim Cyb as president and Sahir Azam as an independent board member.
Tiger Global Leads $146M Funding Round for Temporal, Raising Valuation to $1.72B
Temporal, a Seattle startup that offers an open-source microservices orchestration platform, raised $146 million in a funding round led by Tiger Global, boosting its valuation to $1.72 billion. The company serves major clients like Snap and Netflix, with a reported 4.4X revenue growth in 18 months.
Organizations
-
Temporal President · current
